Using electrical stimulation to treat mild to moderate ulcerative colitis
A Multicenter Randomized Controlled Trial of Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
NA · Xijing Hospital · NCT06231264
This study is testing if a new electrical treatment can help people with mild to moderate ulcerative colitis feel better and improve their health.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Xijing Hospital (other) |
| Locations | 4 sites (Xi'an, Shaanxi and 3 other locations) |
| Trial ID | NCT06231264 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness and safety of transcutaneous electrical acustimulation in patients suffering from mild to moderate ulcerative colitis. Participants will receive either active treatment at designated sites or sham treatment to compare outcomes. The study aims to determine if this non-invasive approach can improve symptoms and overall health in affected individuals. Patients will be monitored for changes in their condition and any potential side effects.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a diagnosis of mild to moderate ulcerative colitis who have not responded to at least one medical treatment.
Not a fit: Patients with treatment-naive ulcerative colitis or those with acute severe cases may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide a new, non-invasive option for managing ulcerative colitis symptoms.
How similar studies have performed: While this approach is relatively novel, similar studies exploring electrical stimulation for gastrointestinal conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years 2. Ulcerative colitis diagnosed for at least 3 mouths. 3. Mayo score 4-10, Mayo endoscopic score 2-3 points 4. Resistant to at least one type of medical treatments Exclusion Criteria: 1. Treatment-naive ulcerative colitis (no previous treatment) 2. Acute severe ulcerative colitis 3. Previous surgical treatment or severe colitis at imminent risk of surgery infective colitis 4. Other systemic diseases 5. Pregnancy and lactation 6. Allergic to the electrode patch
Where this trial is running
Xi'an, Shaanxi and 3 other locations
- Honghui hospital — Xi'an, Shaanxi, China (RECRUITING)
- Second Affiliated Hospital of Xi 'an Jiaotong University — Xi'an, Shaanxi, China (RECRUITING)
- Tangdu Hospital — Xi'an, Shaanxi, China (RECRUITING)
- Xijing Hospital — Xi'an, Shaanxi, China (RECRUITING)
Study contacts
- Principal investigator: Kaichun Wu — Xijing Hospital
- Study coordinator: Jian Wan
- Email: 408127528@qq.com
- Phone: +8615529202305
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ulcerative Colitis